サイトカインによる担癌宿主T細胞の応答制御

• Project/Area Number: 06282234
• Research Category: Grant-in-Aid for Scientific Research on Priority Areas (A)
• Allocation Type: Single-year Grants
• Research Institution: Osaka University
• Principal Investigator: 濱岡 利之 (浜岡 利之) 大阪大学, 医学系研究科, 教授 (60028529)
• Co-Investigator(Kenkyū-buntansha): 小野 史郎 大阪大学, 医学系研究科, 助教授 (80127208) ; 緒方 正人 大阪大学, 医学部, 助手 (60224094)
• Project Period (FY): 1994 – 1999
• Project Status: Completed (Fiscal Year 1999)
• Budget Amount: ¥120,000,000 (Direct Cost: ¥120,000,000); Fiscal Year 1999: ¥30,000,000 (Direct Cost: ¥30,000,000); Fiscal Year 1998: ¥30,000,000 (Direct Cost: ¥30,000,000); Fiscal Year 1997: ¥15,000,000 (Direct Cost: ¥15,000,000); Fiscal Year 1996: ¥15,000,000 (Direct Cost: ¥15,000,000); Fiscal Year 1995: ¥15,000,000 (Direct Cost: ¥15,000,000); Fiscal Year 1994: ¥15,000,000 (Direct Cost: ¥15,000,000)
• Keywords: インターロイキン12 / 担癌状態 / T細胞浸潤 / 腫瘍拒絶抗原 / 免疫抑制 / 抗腫瘍機構 / 腫瘍特異免疫 / T細胞-血管内皮細胞相互作用 / 担癌 / IL-12 / IFN-γ / 浸潤 / 血管内皮細胞 / 接着分子 / CD40L / 抗腫瘍免疫 / CTLA-4 / 腫瘍免疫 / iNOS / IDO / リンパ球浸潤 / 担癌宿主 / サイトカインネットワーク / 免疫増強 / T細胞レセプター / TGF-β / IL-6

Research Abstract

担癌状態では癌拒絶抗原提示能を持ったAPC機能は正常であり、抗腫瘍T細胞は担癌早期では一旦は活性化される。しかし癌の進行に伴い応答性が抑制されていく。ここで強調すべきは、一旦誘導された抗腫瘍T細胞は担癌状態の進行により消去されずに、一時的に機能異常が惹起されている点である。ちなみにBALB/Cマウス由来CSA-1M線維肉腫細胞や(B6xC3H)F1マウス由来OV-HM卵巣癌細胞担癌マウスにIL-12を投与すると、腫瘍の完全退縮及び著明な抗腫瘍転移効果を誘導できる。しかも、IL-12投与は抑制された抗腫瘍T細胞のIFN-γ産生能を著明に回復/増強する。またIL-12投与により腫瘍が退縮したマウスでは腫瘍特異免疫が獲得されている。IL-12の抗腫瘍効果は全ての腫瘍系で有効とは限らず、効果をほとんど認めない非奏効性腫瘍系が存在する事がわかった。そして腫瘍周辺部ストローマ形成の有無が、腫瘍局所への抗腫瘍性T細胞浸潤を、更にはIL-12治療の効果を左右する重要な因子である事を報告した。今回、担癌T細胞応答性低下の免疫分子環境を解析した結果、担癌宿主ではとりわけ担癌後期で脾臓中にMac-1陽性のGr-1陽性細胞の著しい増加が認められ、その結果NO産生が増加し、IFN-γ産生に代表されるT細胞応答性が抑制される。しかしT細胞がこのような環境から解放されると、速やかにそれ自身の持つ応答性を回復しうる。またT細胞自身のIL-12応答性は、担癌ステージに関らず差がみられない事が明らかになった。またIL-12によるT細胞腫瘍組織内浸潤の誘導に重要な役割を果たす腫瘍周囲ストローマ形成にはIL-12治療前から腫瘍塊に少数ながらも浸潤しているCD4^+/CD8^+T細胞及びそれらが産生する少量のIFN-γが必要であることより、腫瘍周辺部ストローマの形成は宿主免疫系と腫瘍の相互作用に基づく事が示唆された。

Research Products

• [Publications] Fujiwara, H. et al.: "Molecular mechanisms underlying T cell migration responsible for IL-12-induced tumor regression"Gann Monograph in Cancer Research. 48. 165-176 (1999)
• [Publications] Ogawa, M. et al.: "A critical role for a peritumoral stromal reaction in the induction of T cell migration responsible for IL-12-induced tumor regression"Cancer Res.. 59. 1531-1538 (1999)
• [Publications] Tomura, M. et al.: "A novel function of Vα14^+CD4^+NKT cells : Stimulation of IL-12 production by antigen-presenting cells in the innate immune system"J. Immunol.. 163. 93-101 (1999)
• [Publications] Yashiro-Ohtani, Y. et al.: "Non-CD28 constimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of T cell receptor with rafts"J. Immunol.. 164. 1251-1259 (2000)
• [Publications] Iwasaki, M. et al.: "Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive vs-unresponsive tumor model"Int. Immunol.. (in press). (2000)
• [Publications] Uekusa, Y. et al.: "The development of peritumoral stroma required for IL-12-induced tumor regression depends on the T cell/IFN-γ-involving host-tumor interaction"J. Internatl. Oncol.. (in press). (2000)
• [Publications] Ogawa,M.et al.: "A critical role for a peritumoral stromal reaction in the induction of T cell migration responsible for IL-12 induced tumor regression." Cancer Res.(in press).
• [Publications] Yashiro,Y.et al.: "A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules." Eur.J.Immunol.28. 926-935 (1998)
• [Publications] Wijesuriya,R.et al.: "B cell-mediated down-regulation of IFN-γ and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state." Int.Immunology. 10. 1057-1065 (1998)
• [Publications] Toyo-oka;K.et al.: "A caspase inhibitor protects thymocytes from diverse signal-mediated apoptosis but not from clonal deletion in fetal thymus organ culture." Immunol.Letters. 63. 83-89 (1998)
• [Publications] Tomura,M.et al.: "A critical role for interleukin-18 in the proliferation and activation of NK1.1+CD3-cells." J.Immunol.160. 4738-4746 (1998)
• [Publications] Tomura,M.et al.: "Differential capacities of CD4+,CD8+ and CD4-CD8-T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18." J.Immunol.160. 3759-3765 (1998)
• [Publications] Park,C.-S.et al.: "Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated,naive T cells and TCR-restimulated,activated T cells." J.Immunol.160. 5790-5796 (1998)
• [Publications] Ogawa,M.et al.: "Multiple roles of IFN-γ in the mediation of IL-12-induced tumor regression." Cancer Research. 58. 2426-2432 (1998)
• [Publications] Kosugi,A.et al.: "Physical and functional association between thymic shared antigen-1/shltem cell antigen 2 and the T cell receptor complex." J.Biol.Chem.273. 12301-12306 (1998)
• [Publications] Hosaka,Y.et al.: "Ultrastructure of murine tumour cell lines defective in MHC class I expression before and after interferon-γ treatment." J.Electron Microscopy. 47. 495-503 (1998)
• [Publications] Fujiwara,H.et al.: "Molecular mechanisms underlying T cell migration responsible for IL-12-induced tumor regression." Gann Monograph in Cancer Reseach. (in press).
• [Publications] Ahn,H.-J.et.al.: "Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-γ production follwing IL-12 stimulation." J.Immunol.161. 5893-5900 (1998)
• [Publications] Y.-F. Yang: "Enhanced induction of anti-tumor T cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade:the effect is manifested only at the restricted tumor-bearing stages." Cancer Res.57. 4036-4041 (1997)
• [Publications] W.-G. Yu: "IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways." J. Leukoc. Biol.62. 450-457 (1997)
• [Publications] M. Ogawa: "Enhanced induction of very late antigen 4/1ymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12." Cancer Res.57. 2216-2222 (1997)
• [Publications] H.-J. Ahn: "A mechanism underlying synergy between IL-12 ans IFN-gamma-inducing factor in enhanced production of IFN-gamma." J. Immunol.159. 2125-2131 (1997)
• [Publications] T. Tsutsui: "Administration of IL-12 induces a CD3^+ CD4^- CD8^- B220^+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells." J. Immunol.159. 2599-2605 (1997)
• [Publications] M. Tomura: "A critical role for interleukin-18 in the proliferation and activation of NK1.1^+CD3^- cells." J. Immunol.(in press). (1998)
• [Publications] H.Fujiwara: "Cellular and molecular mechanisms underlying IL-12-induced tumor regression" Annals New York Academy of Science. 32/1067. 447-473 (1996)
• [Publications] H.Fujiwara: "Antitumor and antimetastatic effects of interleukin 12" Cancer Chemother.Pharmacol.18(suppl). S22-S26 (1996)
• [Publications] W.-G.Yu: "Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12" Int.Immunology. 8. 855-865 (1996)
• [Publications] S.Maruo: "IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones" J.Immunol.156. 1748-1755 (1996)
• [Publications] X-G.Tai: "A role for CD9 molecules in T cell activation" J.Exp.Med.184. 753-758 (1996)
• [Publications] K.Toyooka: "CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism" Int.Immunology.8. 159-169 (1996)
• [Publications] J.Mu: "Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interferring with vascular endothelial growth factor activity" Jpn.J.Cancer Res.87. 963-971 (1996)
• [Publications] S.Noda: "Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1(TSA-1)/stem-cell antigen-2(Sca-2)" J.Exp.Med.183. 2355-2360 (1996)
• [Publications] S.Maruo: "B cells regulate CD-40 ligand-induced IL-12 production in antigen-presenting cells(APC) during T cell/APC interactions" J.Immunol.158. 120-126 (1997)
• [Publications] Y.Abe: "A defect in cell-to-cell adhesion via integrin-fibronectin interactions in a highly metastatic tumor cell line" Jpn.J.Cancer Res.88. 64-71 (1997)
• [Publications] H.Takenaka: "Regulation of T cell-dependent and-independent IL-12 production by three Th2-type cytokines IL-10,IL-6 and IL-4" J.Leukocyte Biol.61. 80-87 (1997)
• [Publications] X.-G.Tai: "Expression of inducible type of nitric oxide(NO)synthase in the thymus and involvement of NO in deletion of T cell receptor-stimulated double positive thymocytes" J.Immunol.(in press). (1997)
• [Publications] T.Furuyama: "Identification of a novel transmembrane semaphorin expressed on lymphocytes" J.Biol.Chem.(in press). (1997)
• [Publications] T.Hirota: "Mouse CD4 and CD8 T-cell clones that recognize xeno-antigens directly on xeno-antigen presenting cells in xeno MHC-restricted ways" Transplant Proc.(in press). (1997)
• [Publications] S.Maruo: "Estabishment of an IL-12-dependent T cell clone:Its characterization and utilization to quantitation of IL-12 activity" J.Leukocyte Biol.(in press). (1997)
• [Publications] T.Hirota: "Direct recognition of rat MHC antigens on rat antigen-presenting cells by mouse CD4+ and CD8+ T cells and establishment of T cell clones exhibiting a direct recognition pathway" Transplantation. (in press). (1997)
• [Publications] Kosugi,A.,et al: "A physiological interaction of T cells and Mac-1^+ cells is not necessary to induce the selective loss of CD3ζ chains in tumor-bearing state." Immunol.Letter. 47. 233-235 (1995)
• [Publications] Yamamoto,N.,et al: "Regulatory mechanisms for production of IFN-γ and TNF by anti-tumor T cells or macrophages in the tumor-bearing state." J.Immunol.154. 2281-2290 (1995)
• [Publications] Zou,J-P.,et al: "Systemic administration of rIL-12 induces complete tumor regression and protective immunity.response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells." International Immunology. 7. 1135-1145 (1995)
• [Publications] Mu,J,et al: "Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes." Cancer Res.55. 4404-4408 (1995)
• [Publications] Maruo,S.,et al: "IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones." J.Immunol.(in press).
• [Publications] Fujiwara,H.,et al: "Cellular and molecular mechanisms underlying IL12-induced tumor regression." In“Interleukin-12:Cellular and Molecular Immunology of an Important Regulatory Cytokine" Annals of New York Academy of Sciences. (in press).
• [Publications] Yamamoto,N.,et.al.: "Regulatory mechanisms for production of interferon-and tumor necrosisfactor by anti-tumor T cells or macrophages in the tumor-bearing state." J.Immunol.(in press).
• [Publications] Noda,S.,et.al.: "Do structural changes of T cellreceptor complex occur in tumor-bearing rnice?" Jpn.J.Cancer Res.(in press).
• [Publications] Zou,J.P.,et.al.: "Recovery of anti tumor CD4^+ T cell responsiveness,suppressed inthe tumor-bearing state,by release fromtumor-bearing" J.Cancer Res.Clin.Oncol.120. 279-285 (1994)
• [Publications] Ogata,M.,et.al.: "cDNA clining and characterization of a novel receptor-type tyrosine phoshatase predominantly expressed in the brain." J.Biol.Chem.250. 2337-2343 (1994)
• [Publications] Ogata,M.,et.al.: "Developmentally regulated expression of a murine receptor-type protein tyrosine phosphatase in the thyrnus." J.Immunol.153. 4478-4487 (1994)
• [Publications] Kosugi,A.,et.al.: "Activation-induced expression of thymic shared antigen-1 ONT lymphocytes and its inhibitory role for T cellreceptor-mediated IL-2 production." Int.Immunol.6. 1967-1976 (1994)